Pretherapeutic uracil and dihydrouracil levels in saliva of colorectal cancer patients are associated with toxicity during adjuvant 5-fluorouracil-based chemotherapy

被引：0
|
作者：
Göran Carlsson
Elisabeth Odin
Bengt Gustavsson
Yvonne Wettergren
机构：
[1] the Sahlgrenska Academy at University of Gothenburg,Department of Surgery, Institute of Clinical Sciences, Sahlgrenska University Hospital/Östra
来源：
Cancer Chemotherapy and Pharmacology | 2014年 / 74卷
关键词：
Dihydrouracil; Uracil; Saliva; Dihydropyrimidine dehydrogenase; 5-FU; Colorectal cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：757 / 763
页数：6
相关论文
共 50 条
  • [31] JAB1-STAT3 activation loop is associated with recurrence following 5-fluorouracil-based adjuvant chemotherapy in human colorectal cancer
    Kugimiya, Naruji
    Nishimoto, Arata
    Hosoyama, Tohru
    Ueno, Koji
    Takemoto, Yoshihiro
    Harada, Eijiro
    Enoki, Tadahiko
    Hamano, Kimikazu
    ONCOLOGY LETTERS, 2017, 14 (05) : 6203 - 6209
  • [32] Predictors of toxicity-related hospitalization in four randomized studies of 5-fluorouracil-based chemotherapy in metastatic colorectal cancer
    Omar Abdel-Rahman
    Osama Ahmed
    International Journal of Colorectal Disease, 2019, 34 : 675 - 680
  • [33] Advanced colorectal cancer in the elderly: results of consecutive trials with 5-fluorouracil-based chemotherapy
    Silvana Chiara
    Maria Teresa Nobile
    Maura Vincenti
    Rita Lionetto
    Alberto Gozza
    Maria Cristina Barzacchi
    Ornella Sanguineti
    Lazzaro Repetto
    Riccardo Rosso
    Cancer Chemotherapy and Pharmacology, 1998, 42 : 336 - 340
  • [34] Predictors of toxicity-related hospitalization in four randomized studies of 5-fluorouracil-based chemotherapy in metastatic colorectal cancer
    Abdel-Rahman, Omar
    Ahmed, Osama
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2019, 34 (04) : 675 - 680
  • [35] Prognostic value of 5-fluorouracil metabolic enzyme genes in Dukes' stage B and C colorectal cancer patients treated with oral 5-fluorouracil-based adjuvant chemotherapy
    Yamada, Hideki
    Iinuma, Hisae
    Watanabe, Toshiaki
    ONCOLOGY REPORTS, 2008, 19 (03) : 729 - 735
  • [36] ASSOCIATION BETWEEN POORLY DIFFERENTIATED CLUSTERS AND EFFICACY OF 5-FLUOROURACIL-BASED ADJUVANT CHEMOTHERAPY IN STAGE III COLORECTAL CANCER.
    Tajima, Y.
    Shimada, Y.
    Wakai, T.
    Okamura, T.
    Yagi, R.
    Kameyama, H.
    DISEASES OF THE COLON & RECTUM, 2016, 59 (05) : E206 - E206
  • [37] Adjuvant chemotherapy with 5-fluorouracil and folinic acid in colorectal cancer: Evaluation of toxicity
    Hartung, G
    Queisser, W
    Diezler, P
    Hagmuller, E
    Edler, L
    Jacob, I
    Wojatschek, C
    Seifert, A
    Weiss, H
    Weh, HJ
    Hoffknecht, M
    Clemens, MR
    Fritze, D
    Katz, R
    Harle, M
    ONKOLOGIE, 1996, 19 (01): : 62 - 67
  • [38] Colonic Methane Production Modifies Gastrointestinal Toxicity Associated With Adjuvant 5-Fluorouracil Chemotherapy for Colorectal Cancer
    Holma, Reetta
    Korpela, Riitta
    Sairanen, Ulla
    Blom, Mikko
    Rautio, Merja
    Poussa, Tuija
    Saxelin, Maija
    Osterlund, Pia
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2013, 47 (01) : 45 - 51
  • [39] Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity
    Prado, Carla M. M.
    Baracos, Vickie E.
    McCargar, Linda J.
    Mourtzakis, Marina
    Mulder, Karen E.
    Reiman, Tony
    Butts, Charles A.
    Scarfe, Andrew G.
    Sawyer, Michael B.
    CLINICAL CANCER RESEARCH, 2007, 13 (11) : 3264 - 3268
  • [40] Prognostic predictors in breast cancer patients with postoperative 5-fluorouracil-based chemotherapy
    Hakamada, Y
    Tsuchida, A
    Arima, M
    Kubouchi, T
    Tokita, H
    Ota, D
    Kaise, H
    Aoki, T
    Kusama, M
    Aoki, T
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2005, 16 (02) : 309 - 314
12345